Dr. Petrylak on Novel Immunotherapy Research in Bladder Cancer OncLive 1:01 8 years ago 204 Далее Скачать
Dr. Petrylak on Immunotherapy for Second-line Treatment in Bladder Cancer OncLive 1:41 9 years ago 221 Далее Скачать
Dr. Petrylak on FDA Approval of Pembrolizumab in Bladder Cancer OncLive 0:38 7 years ago 151 Далее Скачать
Dr. Petrylak on FDA Approval of Nivolumab in Bladder Cancer OncLive 0:37 7 years ago 243 Далее Скачать
Dr. Petrylak on Ongoing Investigations of Checkpoint Inhibition in Bladder Cancer OncLive 0:56 7 years ago 40 Далее Скачать
Dr Daniel Petrylak Explains PD-1, PD-L1 Expression in Bladder Cancer Treatment AJMCtv 1:53 9 years ago 152 Далее Скачать
Daniel P. Petrylak, MD, on immunotherapy & chemotherapy combinations in metastatic bladder cancer OBRoncology 0:58 6 years ago 22 Далее Скачать
Dr. Daniel Petrylak on the IMvigor Study of Atezolizumab in Advanced Bladder Cancer Targeted Oncology 1:29 8 years ago 1 596 Далее Скачать
Dr. Daniel Petrylak on Early Trials for a New Urothelial Bladder Cancer Treatment Targeted Oncology 1:06 9 years ago 319 Далее Скачать
Updates on Immunotherapy for Bladder Cancer Grand Rounds in Urology 3:32 6 years ago 261 Далее Скачать
Daniel Petrylak, MD, on treating bladder cancer patients progressing on checkpoint inhibitors OBRoncology 1:11 7 years ago 26 Далее Скачать
Dr. Petrylak Discusses BCG for the Treatment of Patients With Non-Invasive Bladder Cancer Targeted Oncology 1:06 9 years ago 1 804 Далее Скачать
Dr. Petrylak on Combinations with Pembrolizumab in Urothelial Carcinoma OncLive 1:05 7 years ago 68 Далее Скачать
Management of BCG Unresponsive Cystectomy Ineligible Bladder Cancer Patients Pembrolizumab Grand Rounds in Urology 10:35 3 years ago 1 317 Далее Скачать
